For the readers interested in the stock health of Bruker Corporation (BRKR). It is currently valued at $68.44. When the transactions were called off in the previous session, Stock hit the highs of $69.08, after setting-off with the price of $67.98. Company’s stock value dipped to $67.98 during the trading on the day. When the trading was stopped its value was $68.31.Recently in News on November 14, 2022, Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio. Delivers Simultaneous Multi-Region Neural Imaging of Free-Behaving Animals. You can read further details here
Bruker Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $83.69 on 01/03/22, with the lowest value was $48.42 for the same time period, recorded on 09/27/22.
Bruker Corporation (BRKR) full year performance was -11.88%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bruker Corporation shares are logging -21.53% during the 52-week period from high price, and 41.35% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $48.42 and $87.22.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 314837 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bruker Corporation (BRKR) recorded performance in the market was -18.44%, having the revenues showcasing 12.49% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 10.07B, as it employees total of 7765 workers.
The Analysts eye on Bruker Corporation (BRKR)
During the last month, 0 analysts gave the Bruker Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 60.37, with a change in the price was noted +3.45. In a similar fashion, Bruker Corporation posted a movement of +5.31% for the period of last 100 days, recording 727,934 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BRKR is recording 1.23 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.21.
Technical rundown of Bruker Corporation (BRKR)
Raw Stochastic average of Bruker Corporation in the period of last 50 days is set at 87.50%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 78.71%. In the last 20 days, the company’s Stochastic %K was 73.23% and its Stochastic %D was recorded 68.43%.
Considering, the past performance of Bruker Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -18.44%. Additionally, trading for the stock in the period of the last six months notably improved by 16.85%, alongside a downfall of -11.88% for the period of the last 12 months. The shares increased approximately by 0.16% in the 7-day charts and went down by 12.58% in the period of the last 30 days. Common stock shares were driven by 12.49% during last recorded quarter.